N-PORT filing recap · April 2020

What did ARK Genomic Revolution ETF buy in April 2020?

Reported stock-position changes between this filing and the previous one. These are ARK Genomic Revolution ETF's own holdings, not the firm's.

Stock value

$779.82M

Positions

Estimated turnover

—

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

ILMNIllumina, Inc.$70.06Mreported value+219.6K shares ARCTArcturus Therapeutics Holdings Inc.$69.99Mreported value+2.03M shares NVTAInvitae Corp$69.88Mreported value+4.22M shares CRSPCrispr Therapeutics AG$62.12Mreported value+1.26M shares CGENCompugen Ltd$61.48Mreported value+4.24M shares IOVAIovance Biotherapeutics Inc$34.93Mreported value+1.09M shares NTLAIntellia Therapeutics, Inc.$34.63Mreported value+2.57M shares EDITEditas Medicine, Inc.$28.38Mreported value+1.23M shares TWSTTwist Bioscience Corporation$24.66Mreported value+754.0K shares VCYTVeracyte, Inc.$24.54Mreported value+909.9K shares CERSCerus Corporation$24.27Mreported value+3.95M shares CDNACaredx, Inc.$23.42Mreported value+922.7K shares INCYIncyte Corporation$23.35Mreported value+239.1K shares GHGuardant Health, Inc.$22.31Mreported value+289.9K shares CLLSCellectis SA$20.49Mreported value+1.57M shares NSTGNanostring Technologies Inc$19.00Mreported value+598.3K shares SYRSEURSyros Pharmaceuticals, Inc.$18.24Mreported value+2.16M shares PACBPacific Biosciences of California, Inc.$17.89Mreported value+5.41M shares FATEFate Therapeutics, Inc.$17.79Mreported value+649.8K shares CDXSCodexis, Inc.$13.45Mreported value+1.16M shares PSNLPersonalis, Inc.$13.40Mreported value+1.29M shares PEverpure, Inc.$12.88Mreported value+894.2K shares INOInovio Pharmaceuticals, Inc.$12.75Mreported value+1.06M shares MCRB1EURSeres Therapeutics, Inc.$9.17Mreported value+2.49M shares CSTLCastle Biosciences, Inc.$7.98Mreported value+258.1K shares IONSIonis Pharmaceuticals, Inc.$7.33Mreported value+132.1K shares TDOCTeladoc Health, Inc.$7.09Mreported value+43.1K shares PSTIPluristem Therapeutics Inc$7.09Mreported value+772.8K shares CBMGCellular Biomedicine Group Inc$6.78Mreported value+467.8K shares TXG10x Genomics, Inc.$5.99Mreported value+75.1K shares ADPTAdaptive Biotechnologies Corporation$3.94Mreported value+123.2K shares ONVOOrganovo Holdings Inc$3.24Mreported value+7.65M shares AQBAquabounty Technologies Inc$955.3Kreported value+536.7K shares EVGNEvogene Ltd.$329.9Kreported value+299.9K shares PGENPrecigen, Inc.$1.3Kreported value+351 shares BLCMEURBellicum Pharmaceuticals Inc$280reported value+56 shares